Randomized controlled trial comparing laparoscopic greater curvature plication versus laparoscopic sleeve gastrectomy by Grubnik, V. V. et al.
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/283569514
Randomized controlled trial comparing laparoscopic greater curvature
plication versus laparoscopic sleeve gastrectomy
Article  in  Surgical Endoscopy · November 2015
DOI: 10.1007/s00464-015-4373-9
CITATIONS
16
READS
74
1 author:
Some of the authors of this publication are also working on these related projects:
Laparoscopic band-separated gastric bypass View project
A study of life expectancy in patients with metabolic syndrome after weight loss: a comparative randomized clinical trial View project
Oral Ospanov
Astana Medical University
25 PUBLICATIONS   34 CITATIONS   
SEE PROFILE
All content following this page was uploaded by Oral Ospanov on 29 November 2016.
The user has requested enhancement of the downloaded file.
Randomized controlled trial comparing laparoscopic greater
curvature plication versus laparoscopic sleeve gastrectomy
V. V. Grubnik1,2,3 • O. B. Ospanov4,5 • K. A. Namaeva4 • O. V. Medvedev1 •
M. S. Kresyun1
Received: 26 February 2015 / Accepted: 19 June 2015
 Springer Science+Business Media New York 2015
Abstract
Background Laparoscopic greater curvature plication
(LGCP) is a new restrictive bariatric procedure, which has
a similar restrictive mechanism like laparoscopic sleeve
gastrectomy (LSG) without potential risk of leak. Aim of
the study was to compare 2-year outcomes of LSG and
LGCP.
Methods Multicenter prospective randomized trial was
started in 2010. A total of 54 patients with morbid obesity
were allocated either to LGCP group (n = 25) or LSG
group (n = 27). Main exclusion criteria were: ASA[ III,
age[ 75 and BMI[ 65 kg/m2. There were 40 women and
12 men, and the mean age was 42.6 ± 6.8 years (range
35–62). Data on the operation time, complications, hospital
stay, body mass index loss, percentage of excess weight loss
(%EWL), loss of appetite and improvement in comorbidi-
ties were collected during the follow-up examinations.
Results All procedures were completed laparoscopically.
The mean operative time was 92.0 ± 15 min for LSG and
73 ± 19 min for LGCP (p[ 0.05). The mean hospital stay
was 4.0 ± 1.9 days in the LSG group and 3.8 ± 1.7 days
in LGCP group (p[ 0.05). One year after surgery, the
mean %EWL was 59.5 ± 15.4 % in LSG group and
45.8 ± 17 % in LGCP group (p[ 0.05). After 2 years,
mean %EWL was 78.9 ± 20 % in the LSG group and
42.4 ± 18 % in the LGCP group (p\ 0.01). After 3 years,
mean %EWL was 72.8 ± 22 in the LSG group and only
20.5 ± 23.9 in the LGCP group (p\ 0.01). Loss of feeling
of hunger after 2 years was 25 % in LGCP group and
76.9 % in the LSG group (p\ 0.05). The comorbidities
including diabetes, sleep apnea and hypertension were
markedly improved in the both groups after surgery.
Conclusion The short-term outcomes demonstrated equal
effectiveness of the both procedures, but 2-year follow-up
showed that LGCP is worse than LSG as a restrictive
procedure for weight loss.
Keywords Morbid obesity  Laparoscopic greater
curvature plication  Laparoscopic sleeve gastrectomy
Bariatric surgery is currently considered to efficiently
produce long-term weight loss, improve comorbidities and
improve quality of life in morbidly obese patients [1].
Laparoscopic sleeve gastrectomy (LSG) has evolved from
the first step of two-step procedure (duodenal switch) ini-
tially designed for the super-morbidly obese patients.
During the past decade, LSG has enormously grown in
popularity worldwide [2, 3]. Numerous studies show sim-
ilar metabolic improvement and weight reduction after
LSG compared to laparoscopic Roux-en-Y gastric bypass
(LRYGB) [4–9]. As demonstrated in the literature, two
major complications of LSG are staple line leaks and
gastric bleeding, with the incidence of 1.2 and 3.6 %,
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and Other Interventional Techniques 
respectively [10, 11]. Both complications are difficult to
treat.
To reduce serious complications, a novel restrictive
technique was introduced: laparoscopic greater curvature
plication (LGCP). The mechanism of LGCP is notably
similar to that of LSG: Both result in gastric tube formation
and elimination of the greater curvature, but LGCP has the
advantages of a reversible restrictive technique without
gastrectomy and no risk of leakage from the staple line.
However, the long-term efficacy is under investigation.
There are few studies comparing it with LSG [22, 25].
The primary objective of this prospective randomized
study was to compare early and long-term results of LSG
and LGCP.
Materials and methods
Patients
Prospective randomized study was conducted in two cen-
ters: Odessa National Medical University (Odessa,
Ukraine) and Astana Medical University (Astana, Kaza-
khstan) from January, 2010 to December, 2014. The
inclusion criteria were as follows: body mass index (BMI)
over 35 kg/m2, age of 18–75 years and patient’s avail-
ability for follow-up. The exclusion criteria were: BMI
over 65 kg/m2, age over 75 years, history of supra-umbil-
ical laparotomy, major psychological instability, and
patient’s unfit for general anesthesia, or American society
of anesthesiology (ASA) risk score[ III.
Informed consent was obtained from all patients inclu-
ded in the study. The study was approved by the local
ethical committee.
A total of 54 patients were enrolled into the study. Two
patients were excluded from the study: one patient due to
age above 75 years and another because of the history of
supraumbilical laparotomy. The randomization was
obtained through Random Allocation Software (version
1.0, 2004, Mahmood Saghaei, Isfahan, Iran). The patients
were randomized into two groups: LGCP group—25
patients, and LSG group—27 patients (Fig. 1). All patients
underwent a multidisciplinary evaluation by physician,
psychiatrist and surgeon. Blood tests, abdominal ultra-
sonography, upper GI endoscopy, barium swallow exami-
nation and fat sequencing were performed preoperatively
to establish a baseline. The comorbidities were screened
pre- and postoperatively. The characteristics of the patients
were similar in the two groups (Table 1).
All the patients were followed up at 1, 3, 6, 12, 24 and
36 months postoperatively. Factors analyzed included:
operative time, hospital stay, postoperative complications,
feeling of hunger, BMI loss (BMIL), percentage of excess
weight loss (%EWL) and changes in comorbidities.
Surgical technique
Closed pneumoperitoneum of 12–14 mm Hg was achieved
using a Veress needle. Trocar placement was as follows:
10-mm trocar above the umbilicus for the 30 laparoscope;
12-mm trocar on the right at anterior axillary line; 5-mm
trocar below the xiphoid for liver retraction; another 5-mm
trocar in the midline at the midpoint between xiphoid and
umbilicus for suturing and the surgeon’s right hand.
Using 5- or 10-mm LigaSure device (Valleylab, Boul-
der, USA), the omentum and gastroepiploic vessels were
dissected from the greater curvature, starting at 4 cm from
the pylorus and continuing up to the left crus of the dia-
phragm and the angle of His. The short gastric vessels,
posterior gastric vein and posterior gastric attachments
Assessed for eligibility (n=54)
Excluded 2 patients: 1 patients 
above 65 and 1 patients with 
history of upper laparotomy
Randomized (n=52)
allocated to LGCP (n=25) allocated to LSG (n=27)
analyzed 24 patients analyzed 26 patients
Enrollment
1 patient lost to follow-up1 patient lost to follow-up
Follow up
Analysis
Fig. 1 Diagram of randomized trial
Table 1 Population description
Characteristic LGC patients
(n = 25)
LSG patients
(n = 27)
p
Gender, n (%)
Male—12 5 (20 %) 7 (25.9 %) NS
Female—40 20 (80 %) 20 (74.1 %) NS
Age, years 40.5 ± 5.2 44.2 ± 6.8 NS
BMI, kg/m2 41.6 ± 6.5 45.8 ± 7.2 NS
Comorbidity, n (%)
Hypertension 5 (20 %) 7 (25.9 %) NS
Diabetes 2 (8 %) 3 (11 %) NS
Sleep apnea 4 (16 %) 5 (18.5 %) NS
Joint pain 2 (8 %) 4 (14.8 %) NS
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were carefully divided. A 32-Fr nasogastric tube was
inserted and directed toward the pylorus.
Laparoscopic sleeve gastrectomy
Gastric transection started 4 cm proximal to the pylorus
using Echelon Flex Endopath with 60 mm green reload
(Ethicon, Somerville, USA). The staplers were placed
approximately 1 cm from the tube in the direction of the
gastroesophageal junction. After completing the transec-
tion, bleeding points were secured using 10-mm endoclips
or Vicryl 3-0 (Ethicon, Somerville, USA) intracorporal
sutures. In every case, we oversewed the staple line, using
Ethibond 3-0 (Ethicon, Somerville, USA) continuous
suture. The transected stomach was then removed through
the right 12-mm port. Air was injected into the stomach,
and the staple line was inspected carefully for leaks.
Abdominal drain was removed on the third postoperative
day after the patient started oral feeding.
Laparoscopic greater curvature plication
After omentum dissection, a row of 8–10 extramucosal
interrupted sutures of Ethibond 2-0 (Ethicon, Somerville,
USA) sutures was placed just below the angle of His and
continued distally to 4 cm of the pylorus over the 32-F
gastric tube. The second row of extramucosal running
sutures of Ethibond 2-0 (Ethicon, Somerville, USA) was
used as reinforcement and to narrow the stomach. No leak
test was performed.
Postoperative care
In the LGCP group, proton pump inhibitors (PPI) were
administered intravenously during the postoperative per-
iod. Patients were discharged once they tolerated a liquid
diet without vomiting. Patients were advised to eat soft diet
15 days after surgery and full diet 30 days after surgery. A
daily single-dose PPI was prescribed for 30 days. In the
LSG group, gastrointestinal radiography was done on the
second postoperative day. Patients were allowed to drink
clear fluids on the third postoperative day. Patients resumed
a normal diet in 3 weeks.
Statistical analysis
Statistical analysis in this study was performed using Sta-
tistica 10.0 (StatSoft, Tulsa, USA) software. For continu-
ous variables, descriptive statistics were calculated and
were determined as mean ± standard deviation (SD). Chi-
square test was used for categorical variables, and Wil-
coxon test was used to detect differences in the mean of
continuous variables. P values \0.05 were considered
significant.
Results
From February, 2010 until December, 2011, a total of 54
patients were assessed for enrollment in the study. Two
patients were not included due to age above 75 (1 patient)
and history of supra-umbilical laparotomy (one patient).
Fifty-two patients were enrolled in the study and random-
ized to LGCP group (25 patients) and LSG group (27
patients).
In the LGCP group, five patients had hypertension, two
patients had type two diabetes mellitus, four patients had
obstructive sleep apnea syndrome (OSAS) and two patients
had joint pain (Table 1). In the LSG group, seven patients
had hypertension, three patients had type two diabetes
mellitus, five patients had OSAS and four patients had joint
pain. Both groups were comparable in BMI, sex, gender
and comorbidities (Table 1).
All procedures were performed laparoscopically without
conversions. The mean operative time was 73 ± 19 min
(range 65–115 min) in the LGCP group and 92.0 ± 15 min
(range 80–128 min) in the LSG group, and the difference
was statistically insignificant (p[ 0.05). No leaks or
thromboembolism was observed in either group. Bleeding
from staple line developed in one patient after LSG. The
patient needed re-laparoscopy and suturing of bleeding
vessels. Early episodes of nausea and vomiting, sialorrhea
and abdominal pain were recorded in both groups
(Table 2). These symptoms resolved spontaneously in
7–10 days in all the cases.
Mean hospital stay was similar in both groups:
3.8 ± 1.7 days (3–7 days) in the LGCP group and
4.0 ± 1.9 days (3–8 days) in the LSG group (p[ 0.05). A
mean follow-up of patients of both groups was
25.5 months (range 13–38 months). There were differ-
ences in loss of hunger feeling at 6, 12 and 24 months
postoperatively (Table 3).
The BMI and %EWL at 6, 12, 24 and 36 months post-
operatively in the two groups are listed in Table 4.
Table 2 Early postoperative complications
Complication LGCP, n (%) LSG, n (%) p
Bleeding – 1 (3.7 %) NS
Nausea 4 (16 %) 2 (7.4 %) NS
Vomiting 2 (8 %) – NS
Sialorrhea 5 (20 %) 1 (3.7 %) NS
Abdominal pain 3 (12 %) 1 (3.7 %) NS
Total 14 (56 %) 5 (18.5 %) NS
Surg Endosc
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In LSG group, patients had a greater %EWL after sur-
gery compared to those in LGCP group. At 1 year after the
procedure, %EWL was 45.8 ± 17 % in LGCP group and
59.5 ± 15.4 % in the LSG group (p[ 0.05). But at 2 and
3 years after procedures, %EWL was significantly higher
in LSG group (Table 4). At 2 years after procedures, %
EWL was 78.9 ± 20.0 % in LSG group and
42.4 ± 18.0 % in LGCP group (p\ 0.01). After 3 years,
% EWL was 72.8 ± 22.0 % in LSG group and only
20.5 ± 23.9 % in LGCP group (p\ 0.01).
Gastroesophageal reflux was observed in one patient in
each group after 1–2 years postoperatively. No malnutri-
tion was detected in patients of each group after 2 and
3 years. After 6- to 12-month follow-up, the comorbidities
such as diabetes mellitus, OSAS, hypertension and joint
pain improved in both groups (Table 5). However, in LSG
group there were significantly more remissions. The best
results of comorbidity improvement or resolution was
noticed in hypertension, where 71.4 % of patients after
LSG resolved and 28.6 % improved in 1 year.
Discussion
Sleeve gastrectomy has gained an enormous popularity as a
sole bariatric procedure in the last years [12]. Many pub-
lications have documented significant weight loss in spite
of differences in many variables such as bougie size, antral
resection, stapling flush with the bougie and cuff of tissue
left at the gastroesophageal junction [13]. Himpens et al.
[8] reported the long-term outcome of LSG, stating that the
mean excess weight loss exceeded 50 % after 6 and more
years. There was an improvement in comorbidities,
including type two diabetes, hypertension and OSAS, in
more than 65 % of cases [14].
The rate of complications after LSG varies between
authors, with bleeding ranging from 0 to 16 % and gastric
leak from 0 to 5.5 % [15, 16]. Leak is considered a major
cause of mortality, which ranges from 0 to 1.7 % [3, 7, 10,
11]. In our study, one patient developed bleeding (3.7 %).
No leaks were observed. To prevent leaks, we avoided
excessively narrowing the sleeve at the incisura and over-
sewed the staple line, like the other authors [16]. Gastric
leak constitutes a major complication, which is difficult to
treat. It significantly prolongs hospital stay and may be a
cause of mortality [3, 10, 13].
For these reasons, the technique of LGCP was intro-
duced. This procedure is intended to obtain the same
results as sleeve gastrectomy, in terms of weight loss, but
with lower complication rate than LSG. Although the first
gastric plication was performed on animal models in 1960s
[17], it was not until 2006 that the first patient results were
published by Talebpour [18]. The American society for
Table 3 Postoperative loss of hunger feeling
Groups Loss of feeling of hunger
6 months 12 months 24 months
LGCP 13 (54.2 %) 6 (25.0 %) 3 (12.5 %)
LSG 22 (84.6 %) 20 (76.9 %) 18 (69.2 %)
p \0.05 \0.05 \0.01
Table 4 Differences in BMIL
and %EWL between LGCP and
LSG groups
Groups Differences at
6 months 12 months 24 months 36 months
LGCP
BMIL, kg/m2 ± SD 6.2 ± 1.8 5.8 ± 1.9 5.3 ± 2.0 3.6 ± 2.2
% EWL, mean ± SD 49.8 ± 15.4 45.8 ± 17 42.4 ± 18 20.5 ± 23.9
LSG
BMIL, kg/m2 ± SD 6.4 ± 1.7 7.9 ± 2.1 10.2 ± 2.5 9.4 ± 2.7
% EWL, mean ± SD 51.8 ± 13.9 59.5 ± 15.4 78.9 ± 20 72.8 ± 22
p value of BMIL [0.05 [0.05 \0.05 \0.01
p value of % EWL [0.05 [0.05 \0.01 \0.01
Table 5 Comorbidity outcomes after 6–12 months
Comorbidity LGCP, n (%) LSG, n (%) p
Hypertension
Remission 1 (4.2 %) 5 (19.2 %) \0.05
Improvement 4 (16.7 %) 2 (7.7 %) NS
Diabetes
Remission 1 (4.2 %) 2 (7.7 %) NS
Improvement 1 (4.2 %) 1 (3.8 %) NS
Sleep apnea
Remission 1 (4.2 %) 4 (15.4 %) \0.05
Improvement 3 (12.5 %) 1 (3.8 %) NS
Joint pain
Remission 1 (4.2 %) 3 (11.5 %) NS
Improvement 1 (4.2 %) 1 (3.8 %) NS
Surg Endosc
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Metabolic and Bariatric Surgery stated in March, 2011, that
gastric plication should be considered an investigational
procedure [19], so this procedure should be performed only
within protocol studies.
Two systematic reviews of literature were published in
2012. Kourkoulos et al. analyzed 11 articles, with a total of
521 patients included in prospective studies [20]. Abdel-
baki et al. analyzed seven articles, with a total of 307
patients treated [21]. Mean follow-up reported for this
emerging procedure does not exceed 12 months. Reported
%EWL in all studies is around 50 % in 6 months, ranging
from 40 to 60 %. An interesting subgroup analysis by Fried
et al. considered two groups of patients with preoperative
BMI of [40 and \40 [22]. Patients with a preoperative
BMI\ 40 had significantly greater percentage BMIL at
6 months than patients with a preoperative BMI of [40.
This significant difference was no longer existed at
9 months. Different EWL in patients with BMI\ 45 or
[45 was reported by Skrekas et al. [23]. Percent EWL was
significantly higher in the group with BMI\ 45, and
inadequate weight loss was doubled in patients with
BMI[ 45 [23]. Results of gastric plication have been
compared with results of sleeve gastrectomy in 39 patients
by Shen et al. [24]. According to them, weight loss was
more significant in the patients after sleeve gastrectomy
than after gastric plication in 1 year after surgery. These
results were different to other studies [21, 23, 24].
The aim of our randomized study was to compare short-
and long-term follow-up results after LGCV and LSG. It
was a multicenter study encompassing two clinics:
University hospital in Odessa (Ukraine) and University
hospital in Astana (Kazakhstan). Fifty-two patients were
randomized to two groups: 25 patients underwent LGCP
and 27 patients underwent LSG. Preoperative BMI was
41.6 ± 6.5 kg/m2 in LGCP group and 45.8 ± 7.2 kg/m2 in
LSG group (p[ 0.1).
Both groups were comparable in BMI, sex, gender and
comorbidities. All operations were performed by senior
surgeons. Intraoperative and postoperative complications
were minimal. No leaks were observed. There was no
mortality in both groups. After LSG, one patient had
bleeding from staple line and was reoperated. The rate of
bleeding in our study was 3.7 %, which is similar to other
studies [12, 13, 15].
After LGCP, the most common complications were
nausea, vomiting and sialorrhea, and the incidence of these
complications in the LGCP group was higher than in the
LSG group. Similar results were described by Shen et al.
[24]. Strekas et al. [23] reported the overall complication
rate 8.8 % after LGCP in 135 patients: micro-leaks from
the suture line (two patients), gastric bleeding (two
patients) and obstruction (three patients). The same com-
plications were reported in the largest study on the subject
that was conducted by Fried et al. [22]. Their results sug-
gested that LGCP cannot eliminate the risk of leaks and
gastric hemorrhage. Brethauer et al. [25] analyzed the
possible mechanism of postoperative gastric perforation
including acute distention of the stomach or severe vom-
iting, which results in full-thickness tear at the suture line
and delayed thermal injury of the stomach that occurred
during division of the short gastric vessels. Our experience
showed that immaculate surgical technique prevents major
complications, such as hemorrhage, leaks and fistula
formation.
Our study showed that although the occurrence of such
early complications as nausea, vomiting and sialorrhea in
the LGCP group was higher than in the LSG group, they
were relatively easy to manage. We agree with the opinion
of other surgeons [24, 26] that the safety of LGCP is
comparable to adjustable gastric banding, which is con-
sidered to have lowest incidence of severe complications of
all bariatric procedures.
Our follow-up data revealed that the difference in
%EWL was not significant between the two groups at
6 months, but at 12, 24 and 36 months there was a sig-
nificant difference between groups. Short-term follow-up
did not show a significant difference in BMIL between the
two groups, but after 24–36 months the difference in
weight loss was 2–3 times more in LSG group. Ramos
et al. [27] reported a series of LGCP in 42 patients who
achieve encouraging weight loss. The mean %EWL was
about 48 % in 6 months and 60 % EWL in 12 months.
Our study shows similar %EWL in 6 months
(49.8 ± 15.4 %), but only 45.8 ± 17 % EWL in
12 months. Such difference in data might be due to the loss
of hunger feeling, which significantly differs at short- and
long-term follow-up. Our data show that at 6 months,
54.2 % of patients after LGCP had loss of feeling of
hunger, but at 12 months it decreased in 25 % of patients
only. Differences in loss of feeling of hunger, BMIL and
%EWL after 24–36 months were significant (\0.001)
between the two procedures.
These differences can be explained by two factors [24].
Firstly, plasma level of ghrelin (the only orexigenic hor-
mone circulating levels of which increase before meals and
decrease with feeding) decreases after LSG, due to resec-
tion of gastric fundus where ghrelin is produced. In LGCP,
which does not include resection of gastric fundus, plasma
ghrelin levels may not decrease as sharply as following
LSG. Secondly, stomach preservation in LGCP involves
the relaxation of the stomach muscular layer and may result
in gastric volume enlargement after 6 months. Skrekas
et al. [23] found out by endoscopy that in patients with
inadequate weight loss, the gastric capacity was noticeably
increased in 6 months after LGCP. Our results showed the
remarkable improvement in comorbidities in both groups.
Surg Endosc
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At the same time, our results demonstrated that at long-
term follow-up, LSG is more effective for decreasing
comorbidities. This may be multifactorial due to hormonal
alteration [28], BMI loss and decrease in carbohydrate
absorption [29] after bariatric surgery.
Conclusion
LGCP is a feasible and safe bariatric procedure for mor-
bidly obese patients. Unlike LSG, LGCP is reversible. At
short-term follow-up, LGCP and LSG yield comparable
results. However, long-term follow-up demonstrates that
LGCP is a less effective procedure for treatment of mor-
bidly obese patients.
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